Exscientia | Investor Presentation Deck | 93 slides · page 88 of 93
The slide presents preclinical efficacy data for a MALT1 inhibitor ('565) in combination with Ibrutinib.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
chart 2/2 list 2/2 source-note 1/1 title 2/2
Components 7
line line bullet bullet source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.